|
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
RECRUITINGN/ASponsored by University Medical Center Nijmegen
Actively Recruiting
PhaseN/A
SponsorUniversity Medical Center Nijmegen
Started2020-03-01
Est. completion2040-02-17
Eligibility
Age25 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations11 sites
View on ClinicalTrials.gov →
NCT04294927
Summary
The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with respect to ovarian cancer incidence.
Eligibility
Age: 25 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Women with a class 5 (definitely pathogenic) BRCA1, BRCA2, RAD51C, RAD51D or BRIP1 germline mutation in one of the participating centers. * Age at inclusion; * BRCA1: 25-40 years * BRCA2: 25-45 years * RAD51C, RAD51D, BRIP1: 25-50 years * Childbearing completed * Presence of at least one fallopian tube * Participants may have a personal history of non-ovarian malignancy * Informed consent must be obtained and documented according to national and local regulatory requirements and the local rules followed in the institution. Exclusion Criteria: * Postmenopausal status (natural menopause or due to treatment) * Wish for second stage RRO within two years after RRS * Legally incapable * Prior bilateral salpingectomy * A personal history of ovarian, fallopian tube or peritoneal cancer * Current diagnosis or treatment for malignant disease
Conditions7
BRCA1 Gene MutationBRCA2 Gene MutationBRIP1 Gene MutationCancerOvarian CancerRAD51C Gene MutationRAD51D Gene Mutation
Locations11 sites
Find trials near these locations
Cancer trials in ChicagoCancer trials in BostonCancer trials in New YorkCancer trials in PhiladelphiaCancer trials in HoustonCancer trials in SeattleAll trials in IllinoisAll trials in MassachusettsAll trials in MinnesotaAll trials in MissouriAll trials in New YorkAll trials in North CarolinaAll trials in PennsylvaniaAll trials in TexasAll trials in Washington
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Medical Center Nijmegen
Started2020-03-01
Est. completion2040-02-17
Eligibility
Age25 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations11 sites
View on ClinicalTrials.gov →
NCT04294927